Fujifilm Medical Systems U.S.A., Inc., continues to see growth in enterprise imaging. Fujifilm has secured four new contracts for the implementation of various products from its comprehensive Synapse Enterprise Imaging portfolio, including Synapse 5 PACS, Synapse 3D, Synapse VNA, Synapse Mobility Enterprise Viewer and Synapse Cardiovascular.

Today, Medical Group Management Association (MGMA) proudly announces its 2018-2019 Board of Directors.

Just 39 percent of healthcare organizations and providers are confident in their medical device security, according to report by KLAS, College of Healthcare Information Management Executives (CHIMES) and the Association for Executives in Healthcare Information Security (AEHIS).

A deep-learning software that can automatically calculate left ventricular ejection fraction (LVEF) with less variability than a cardiologist recently received approval from the U.S. Food and Drug Administration (FDA).

New data from the Medical Group Management Association (MGMA)’s DataDive Management and Staff Compensation highlights a 19 percent increase in total compensation for nursing staff between 2015 and 2017.

CHICAGO – With well-documented gaps in health and health care across segments of the United States, the American Medical Association (AMA) today adopted policy during its Annual Meeting to define health equity and outline a strategic framework toward realizing the goal of achieving optimal health for all, referring to all aspects of health, including mental and behavioral health. To begin down that path, the AMA will establish a structural or organizational home for the effort, complete with dedicated resources, staff and budget, and a multi-year programmatic roadmap.

A poll conducted by the Medical Group Management Association (MGMA) found most medical practice professionals aren’t aware of the direct primary care (DPC) model where patients pay a flat fee in exchange for easier access to their primary care doctor.

The American Hospital Association (AHA) is lending its support to a bill to change the merger review process at the Federal Trade Commission (FTC), eliminating the agency’s ability to challenge proposed combinations without going to court.